- Phase I study of vorinostat in patients with advanced solid tumors and hepatic dysfunction: a National Cancer Institute Organ Dysfunction Working Group study. Ramalingam, S.S., Kummar, S., Sarantopoulos, J., Shibata, S., LoRusso, P., Yerk, M., Holleran, J., Lin, Y., Beumer, J.H., Harvey, R.D., Ivy, S.P., Belani, C.P., Egorin, M.J. J. Clin. Oncol. (2010)